Bruker (BRKR) net assets (shareholders' equity)

Net assets · fiscal 2025
$2.51B

Bruker (BRKR) had net assets of $2.51B at the end of fiscal 2025 (December 31, 2025). That is 38.3% higher than the $1.82B of fiscal 2024. Figures as of 19 Nov 2026, 11:49 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Net assets, fiscal 2025
$2.51B
Change on fiscal 2024
+38.3%
Growth, 5 years
+21.2% a year
Growth, 10 years
+13.2% a year
Highest on record
$2.51Bfiscal 2025
Lowest on record
$418.80Mfiscal 2009
Fiscal years on record
172009–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Bruker net assets (shareholders' equity), in more detail

Over the five fiscal years to 2025 net assets grew at a compound 21.2% a year; over ten years the rate was 13.2% a year. Across the 17 fiscal years on record (2009–2025), the highest was $2.51B in fiscal 2025 and the lowest $418.80M in fiscal 2009.

History · 17 fiscal years

Net assets by fiscal year

Bruker net assets (shareholders' equity), year by year

Bruker (BRKR) net assets (shareholders' equity) by fiscal year
Fiscal yearNet assetsChangeYear ended
2025$2.51B 38.3% up
2024$1.82B 28.4% up
2023$1.41B 24.9% up
2022$1.13B 5.7% up
2021$1.07B 11.4% up
2020$961.20M 6.0% up
2019$906.80M 1.1% up
2018$896.60M 23.6% up
2017$725.40M 5.7% up
2016$686.40M 5.5% down
2015$726.10M 5.2% down
2014$765.90M 9.5% down
2013$846.10M 19.7% up
2012$706.60M 13.7% up
2011$621.50M 18.4% up
2010$524.70M 25.3% up
2009$418.80M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value.

How to read it

Large buybacks and write-offs shrink it without the business getting worse, so a falling or negative figure needs the reason before a verdict.

Net assets at health care companies of similar size

Net assets of Bruker and comparable companies
CompanyNet assetsFiscal year
Spyre Therapeutics SYRE$715.24M2025
Qiagen QGEN$3.78B2025
Insulet PODD$1.52B2025
Bruker BRKR$2.51B2025
Globus Medical GMED$4.57B2025
Madrigal Pharmaceuticals MDGL$602.69M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on BRKR

Bruker, figure by figure

Bruker (BRKR) overview: price, valuation and scorecardAll health care companies by market value

Bruker net assets (shareholders' equity): questions and answers

What are Bruker's net assets?

Bruker (BRKR) had net assets of $2.51B at the end of fiscal 2025 (December 31, 2025). That is 38.3% higher than the $1.82B of fiscal 2024.

What is the growth rate of Bruker's net assets?

Over the five fiscal years to 2025 net assets grew at a compound 21.2% a year; over ten years the rate was 13.2% a year.

What are the highest and lowest net assets figures on record for Bruker?

Across the 17 fiscal years on record (2009–2025), the highest was $2.51B in fiscal 2025 and the lowest $418.80M in fiscal 2009.

How is Bruker's net assets calculated?

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value. For Bruker it is on record here for 17 fiscal years, 2009 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Bruker (BRKR) net assets (shareholders' equity)”, data as of 19 November 2026. https://funkfolio.com/stock/BRKR/net-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.